Description
91,86,490 equity shares of Suven Life Sciences Ltd listed and permitted to trade from August 28, 2025, issued through warrant conversion at Rs. 134 per share.
Summary
BSE has announced the listing of 91,86,490 new equity shares of Suven Life Sciences Ltd (Scrip Code: 530239) effective from Thursday, August 28, 2025. These shares were issued at a premium of Rs. 133 per share (issue price Rs. 134) to non-promoters through conversion of warrants on a preferential basis.
Key Points
- 91,86,490 equity shares of Rs. 1 each issued at Rs. 134 per share
- Shares issued to non-promoters through warrant conversion
- Distribution numbers: 218073718 to 227260207
- Date of allotment: July 16, 2025
- ISIN: INE495B01038
- New shares rank pari-passu with existing equity shares
Regulatory Changes
No regulatory changes introduced. Standard listing process for warrant conversion.
Compliance Requirements
- Trading members informed of new securities availability for trading
- Lock-in period compliance required until March 9, 2026
- All 91,86,490 shares subject to lock-in restrictions
Important Dates
- Allotment Date: July 16, 2025
- Trading Commencement: August 28, 2025
- Lock-in Period Ends: March 9, 2026
Impact Assessment
The listing represents significant equity dilution for existing shareholders. The warrant conversion at Rs. 134 per share indicates confidence from non-promoter investors. The 18-month lock-in period provides stability but restricts immediate liquidity for new shareholders.
Impact Justification
Significant equity dilution through warrant conversion affecting existing shareholders